Check out the companies making headlines after the bell Tuesday:
Shares of Nike fell in extended trading after the apparel and sports equipment brand posted lower-than-anticipated sales in the latest quarter. Nike reported earnings of 55 cents per share, higher than the 48 cents expected by Thomson Reuters consensus estimates. But revenues came in at $8.03 billion, below the 8.2 billion expected.
Pharmaceutical giants Merck and Gilead moved when a federal jury said Gilead might have to hand over a portion of its revenue from Sovaldi and Harvoni. The hepatitis C treatments, which generate billions in revenue, have been part of a patent dispute between the two companies, Reuters reported.
Merck's shares rose on the news while Gilead share prices dipped, as did competitor Biogen.